⌘K

Login Start Free

Home/Filings/4/0001104659-22-029519

4//SEC Filing

Liu David Y 4

Accession 0001104659-22-029519

CIK 0001377121other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 8:38 PM ET

Size

5.0 KB

Accession

0001104659-22-029519

Insider Transaction Report

Form 4

Period: 2022-02-28

Protagonist Therapeutics, IncPTGX

Chief Scientific Officer

Transactions

Tax Payment
Common Stock
2022-02-28$24.28/sh−2,119$51,449→ 66,538 total

Footnotes (1)

[F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 6,125 vested restricted stock units on February 28, 2022.

Documents

1 file

4
tm228264-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1

filerCIK 0001675881

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 8:38 PM ET
Size: 5.0 KB

View on SEC.gov